Sanofi Historical Income Statement

SNY Stock

USD 48.72 0.44 0.91%

Historical analysis of Sanofi ADR income statement accounts such as Gross Profit of 22 B, Other Operating Expenses of 24.5 B, Operating Income of 6 B or Ebit of 8 B can show how well Sanofi ADR performed in making a profits. Evaluating Sanofi ADR income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Sanofi ADR's future profits or losses.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Sanofi ADR latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Sanofi ADR is a good buy for the upcoming year.

Net Income Gross Profit

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sanofi ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Sanofi Stock please use our How to Invest in Sanofi ADR guide.

About Sanofi Income Statement Analysis

Sanofi ADR Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Sanofi ADR shareholders. The income statement also shows Sanofi investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Sanofi ADR Income Statement Chart

At this time, Sanofi ADR's Selling General Administrative is fairly stable compared to the past year. EBIT is likely to rise to about 8 B in 2024, whereas Depreciation And Amortization is likely to drop slightly above 3.3 B in 2024.

Selling General Administrative Total Revenue Gross Profit Other Operating Expenses Cost Of Revenue Net Interest Income

Total Revenue

Total revenue comprises all receipts Sanofi ADR generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Sanofi ADR minus its cost of goods sold. It is profit before Sanofi ADR operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Sanofi ADR. It is also known as Sanofi ADR overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Cost Of Revenue

Cost of Revenue is found on Sanofi ADR income statement and represents the costs associated with goods and services Sanofi ADR provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Net Interest Income

The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.

Most accounts from Sanofi ADR's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Sanofi ADR current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sanofi ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Sanofi Stock please use our How to Invest in Sanofi ADR guide.At this time, Sanofi ADR's Selling General Administrative is fairly stable compared to the past year. EBIT is likely to rise to about 8 B in 2024, whereas Depreciation And Amortization is likely to drop slightly above 3.3 B in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	26.9B	31.7B	31.8B	22.0B
Total Revenue	39.2B	45.4B	46.0B	31.3B

Gross Profit Total Revenue

Sanofi ADR income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Minority Interest	Selling And Marketing Expenses	Discontinued Operations	Net Income From Continuing Ops	Tax Provision	Interest Income	Extraordinary Items	Net Interest Income	Reconciled Depreciation
Depreciation And Amortization		0.43	0.27	0.32	0.33	0.3	0.38	-0.28	0.17	0.33	0.31	0.29	0.36	0.21	0.2	0.19	0.06	-0.18	-0.38	0.27	0.09	0.38	-0.4	-0.39	-0.33
Interest Expense	0.43		0.14	0.62	0.62	0.65	0.24	0.18	0.55	0.43	0.59	0.68	0.18	-0.14	0.09	0.23	0.18	0.45	-0.14	-0.1	0.14	0.38	-0.13	-0.31	0.14
Selling General Administrative	0.27	0.14		0.31	0.34	0.28	0.29	-0.13	0.29	0.03	0.24	0.3	0.3	0.42	0.13	0.47	-0.89	0.34	-0.22	0.21	0.52	0.55	-0.18	0.25	-0.42
Total Revenue	0.32	0.62	0.31		1.0	0.99	0.63	0.65	0.98	0.83	0.99	0.98	0.6	-0.17	0.57	0.54	-0.08	0.73	0.01	0.21	0.36	0.02	0.06	0.45	0.0
Gross Profit	0.33	0.62	0.34	1.0		0.99	0.62	0.64	0.98	0.82	0.99	0.98	0.6	-0.15	0.56	0.55	-0.1	0.73	0.0	0.2	0.36	0.05	0.05	0.45	-0.02
Other Operating Expenses	0.3	0.65	0.28	0.99	0.99		0.58	0.66	0.98	0.82	0.99	1.0	0.55	-0.22	0.53	0.49	-0.04	0.77	0.03	0.18	0.32	0.06	0.07	0.44	0.08
Operating Income	0.38	0.24	0.29	0.63	0.62	0.58		0.49	0.57	0.71	0.62	0.54	1.0	0.48	0.91	0.8	-0.24	0.34	-0.09	0.84	0.72	-0.15	-0.06	0.38	-0.41
Ebit	-0.28	0.18	-0.13	0.65	0.64	0.66	0.49		0.73	0.82	0.68	0.63	0.49	-0.4	0.57	0.27	0.13	0.63	0.12	0.3	0.18	-0.37	0.17	0.67	0.36
Research Development	0.17	0.55	0.29	0.98	0.98	0.98	0.57	0.73		0.82	0.98	0.97	0.55	-0.23	0.53	0.48	-0.1	0.79	0.03	0.18	0.31	-0.01	0.08	0.56	0.09
Ebitda	0.33	0.43	0.03	0.83	0.82	0.82	0.71	0.82	0.82		0.85	0.79	0.69	-0.26	0.68	0.37	0.17	0.51	-0.11	0.46	0.23	-0.14	-0.07	0.42	0.15
Cost Of Revenue	0.31	0.59	0.24	0.99	0.99	0.99	0.62	0.68	0.98	0.85		0.98	0.6	-0.19	0.59	0.52	-0.02	0.71	0.04	0.22	0.33	-0.03	0.08	0.47	0.03
Total Operating Expenses	0.29	0.68	0.3	0.98	0.98	1.0	0.54	0.63	0.97	0.79	0.98		0.52	-0.23	0.49	0.47	-0.05	0.8	0.02	0.15	0.31	0.12	0.07	0.42	0.12
Income Before Tax	0.36	0.18	0.3	0.6	0.6	0.55	1.0	0.49	0.55	0.69	0.6	0.52		0.49	0.92	0.8	-0.26	0.32	-0.08	0.85	0.72	-0.17	-0.05	0.42	-0.42
Total Other Income Expense Net	0.21	-0.14	0.42	-0.17	-0.15	-0.22	0.48	-0.4	-0.23	-0.26	-0.19	-0.23	0.49		0.36	0.61	-0.54	-0.21	-0.07	0.57	0.66	0.07	-0.07	-0.07	-0.8
Net Income	0.2	0.09	0.13	0.57	0.56	0.53	0.91	0.57	0.53	0.68	0.59	0.49	0.92	0.36		0.78	-0.09	0.38	0.28	0.75	0.74	-0.25	0.3	0.52	-0.35
Income Tax Expense	0.19	0.23	0.47	0.54	0.55	0.49	0.8	0.27	0.48	0.37	0.52	0.47	0.8	0.61	0.78		-0.47	0.4	0.28	0.54	0.9	-0.04	0.31	0.36	-0.55
Minority Interest	0.06	0.18	-0.89	-0.08	-0.1	-0.04	-0.24	0.13	-0.1	0.17	-0.02	-0.05	-0.26	-0.54	-0.09	-0.47		-0.24	0.16	-0.25	-0.51	-0.33	0.13	-0.38	0.39
Selling And Marketing Expenses	-0.18	0.45	0.34	0.73	0.73	0.77	0.34	0.63	0.79	0.51	0.71	0.8	0.32	-0.21	0.38	0.4	-0.24		0.22	0.12	0.4	0.19	0.29	0.57	0.25
Discontinued Operations	-0.38	-0.14	-0.22	0.01	0.0	0.03	-0.09	0.12	0.03	-0.11	0.04	0.02	-0.08	-0.07	0.28	0.28	0.16	0.22		-0.23	0.34	-0.16	1.0	0.28	-0.02
Net Income From Continuing Ops	0.27	-0.1	0.21	0.21	0.2	0.18	0.84	0.3	0.18	0.46	0.22	0.15	0.85	0.57	0.75	0.54	-0.25	0.12	-0.23		0.6	-0.11	-0.2	0.27	-0.37
Tax Provision	0.09	0.14	0.52	0.36	0.36	0.32	0.72	0.18	0.31	0.23	0.33	0.31	0.72	0.66	0.74	0.9	-0.51	0.4	0.34	0.6		0.04	0.37	0.34	-0.55
Interest Income	0.38	0.38	0.55	0.02	0.05	0.06	-0.15	-0.37	-0.01	-0.14	-0.03	0.12	-0.17	0.07	-0.25	-0.04	-0.33	0.19	-0.16	-0.11	0.04		-0.16	-0.3	0.09
Extraordinary Items	-0.4	-0.13	-0.18	0.06	0.05	0.07	-0.06	0.17	0.08	-0.07	0.08	0.07	-0.05	-0.07	0.3	0.31	0.13	0.29	1.0	-0.2	0.37	-0.16		0.33	-0.02
Net Interest Income	-0.39	-0.31	0.25	0.45	0.45	0.44	0.38	0.67	0.56	0.42	0.47	0.42	0.42	-0.07	0.52	0.36	-0.38	0.57	0.28	0.27	0.34	-0.3	0.33		0.03
Reconciled Depreciation	-0.33	0.14	-0.42	0.0	-0.02	0.08	-0.41	0.36	0.09	0.15	0.03	0.12	-0.42	-0.8	-0.35	-0.55	0.39	0.25	-0.02	-0.37	-0.55	0.09	-0.02	0.03

Click cells to compare fundamentals

Sanofi ADR Account Relationship Matchups

Sanofi ADR income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	171.9K	3.3B	3.1B	3.7B	4.8B	3.3B
Interest Expense	465M	434M	403M	472M	1.1B	607.0M
Total Revenue	37.6B	37.4B	39.2B	45.4B	46.0B	31.3B
Gross Profit	25.7B	25.2B	26.9B	31.7B	31.8B	22.0B
Other Operating Expenses	30.5B	29.5B	30.0B	33.5B	38.2B	24.5B
Operating Income	3.1B	14.1B	8.1B	10.7B	7.9B	6.0B
Ebit	15.1B	14.6B	8.4B	10.6B	7.8B	8.0B
Research Development	6.0B	5.5B	5.7B	6.7B	6.7B	4.7B
Ebitda	15.1B	17.9B	11.5B	14.3B	12.6B	11.3B
Cost Of Revenue	12.0B	12.2B	12.3B	13.7B	14.2B	9.3B
Total Operating Expenses	18.5B	17.3B	17.8B	19.8B	23.9B	15.2B
Income Before Tax	2.8B	13.8B	7.8B	10.4B	7.2B	5.5B
Total Other Income Expense Net	(4.1B)	24M	(289M)	(166M)	(722M)	(758.1M)
Net Income	2.8B	12.3B	6.2B	8.4B	5.4B	4.9B
Income Tax Expense	121M	1.8B	1.6B	2.0B	1.6B	1.1B
Net Income Applicable To Common Shares	2.8B	12.3B	6.2B	8.4B	9.6B	5.9B
Minority Interest	174M	146M	(56M)	(113M)	(36M)	(34.2M)
Selling And Marketing Expenses	10.1B	9.9B	9.9B	9.4B	10.8B	9.5B
Net Income From Continuing Ops	2.9B	12.4B	6.3B	6.8B	5.4B	6.3B
Tax Provision	139M	1.8B	1.6B	1.5B	1.6B	1.3B
Interest Income	141M	53M	40M	206M	546M	573.3M
Net Interest Income	(303M)	(337M)	(328M)	(234M)	(639M)	(671.0M)
Reconciled Depreciation	7.5B	3.7B	1.6B	2.1B	4.8B	3.1B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Additional Tools for Sanofi Stock Analysis

When running Sanofi ADR's price analysis, check to measure Sanofi ADR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi ADR is operating at the current time. Most of Sanofi ADR's value examination focuses on studying past and present price action to predict the probability of Sanofi ADR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi ADR's price. Additionally, you may evaluate how the addition of Sanofi ADR to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Sanofi Historical Income Statement

About Sanofi Income Statement Analysis

Sanofi ADR Income Statement Chart

Total Revenue

Gross Profit

Other Operating Expenses

Cost Of Revenue

Net Interest Income

Sanofi ADR income statement Correlations

Sanofi ADR Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Sanofi ADR income statement Accounts

Also Currently Popular

Additional Tools for Sanofi Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Gross Profit	+ 1.0	Total Revenue
Total Operating Expenses	+ 1.0	Other Operating Expenses
Income Before Tax	+ 1.0	Operating Income
Extraordinary Items	+ 1.0	Discontinued Operations
Other Operating Expenses	+ 0.99	Total Revenue
Cost Of Revenue	+ 0.99	Total Revenue

Minority Interest	- 0.89	Selling General Administrative
Reconciled Depreciation	- 0.8	Total Other Income Expense Net
Reconciled Depreciation	- 0.55	Tax Provision
Reconciled Depreciation	- 0.55	Income Tax Expense
Minority Interest	- 0.54	Total Other Income Expense Net
Tax Provision	- 0.51	Minority Interest